Clinical Trial Update: PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes pharmacokinetic and safety evaluation of SAP-001 in adult subjects with normal and impaired renal function across Phase 1 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SAP-001

Snippet

Sponsor: Shanton Pharma Pte. Ltd. | Conditions: Gout, Hyperuricemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING